Long-term effects of whole body cryostimulation on uric acid concentration in plasma of secondary progressive multiple sclerosis patients

References

• Andreassen M, Frystyk J, Miller KK, Kristensen LØ. Interferon-β treatment associated with a biochemical profile suggestive of acromegaly. A case report of patient treated for multiple sclerosis. Scand J Clin Lab Invest 2010;70; 519–22.
   PubMed Web of Science ®Google Scholar
• Miller E. Multiple sclerosis. Adv Exp Med Biol 2012;724: 222–38.
   PubMed Web of Science ®Google Scholar
• Lucchinetti CW, Brück J, Parisi B, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Annals Neurol 2000; 47:707–17.
   PubMed Web of Science ®Google Scholar
• Disanto G, Berlanga A, Handel AE, Para AE, Burrell AM, Fries A, Handunnetthi L, De Luca GC, Morahan JM. Heterogeneity in multiple sclerosis: scratching the surface of complex disease. Autoimmune Dis 2011:ID 932351.
   Google Scholar
• Leoni V. Oxysterols as markers of neurological disease a review. Scand J Clin Lab Invest 2009;69:22–5.
   PubMed Web of Science ®Google Scholar
• Rejdak K, Eikelenboom MJ, Petzold A, Thompson EJ, Stelmasiak Z, Lazeron RH, Barkhof F, Polman CH, Uitdehaag BM, Giovannoni G. CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis. Neurology 2004;26:1439–45.
   Google Scholar
• Miller E, Mrowicka M, Saluk-Juszczak J, Majsterek I. The level of isoprostanes as a non-invasive marker for in vivo lipid peroxidation in secondary progressive multiple sclerosis. Neurochem Res 2012;36:1012–6.
   Web of Science ®Google Scholar
• Kutzing MK, Firenstein BL. Altered uric acid and diseases states. J Pharm Exp Ther 2008;324:1–7.
   PubMed Web of Science ®Google Scholar
• Du Y, Chen CP, Tseng CY Eisenberg Y, Firenstein BL. Astroglia-mediated effects of uric acid to protect spinal cord neurons from glutamate toxicity. Glia 2007;55:463–72.
   PubMed Web of Science ®Google Scholar
• Koch M, De Keyser J. Uric acid in multiple sclerosis. Neurol Res 2006;28:316–9.
   PubMed Web of Science ®Google Scholar
• Hooper DC, Scott GS, Zborek A, Mikheeva T, Kean RB, Koprowski H, Spitsin SV. Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis. FASEB J 2000;14:691–8.
   PubMed Web of Science ®Google Scholar
• Nälsén C, Ohrvall M, Kamal-Eldin A, Vessby B. Plasma antioxidant capacity among middle-aged men; the contribution of uric acid. Scand J Clin Lab Invest 2006;66:239–48.
   PubMed Web of Science ®Google Scholar
• Spitsin S, Hooper DC, Leist T. Inactivation of peroxynitrite in multiple sclerosis patients after oral administration of inosine may suggest possible approaches to therapy of the disease. Mult Scler 2001;7:313–9.
   PubMed Web of Science ®Google Scholar
• Liu B, Shen Y, Xiao K, Tang Y, Cen L, Wei J. Serum uric acid levels in patients with multiple sclerosis: a meta-analysis. Neurol Res 2012;34:163–71.
   PubMed Web of Science ®Google Scholar
• Miller E, Walczak A, Saluk J, Majsterek I. Oxidative modification of patient's plasma proteins and its role in pathogenesis of multiple sclerosis. Clin Biochem 2012;45:26–30.
   PubMed Web of Science ®Google Scholar
• Constantinescu CS, Freitag P, Kappos L. Increase in serum levels of uric acid, an endogenous antioxidant, under treatment with glatiramer acetate for multiple sclerosis. Mult Scler 2000;6:378–81.
   PubMed Web of Science ®Google Scholar
• Guerrero AL, Gutiérrez F, Iglessias F. Serum uric acid levels in multiple sclerosis patients inversely correlate with disability. Neurol Sci 2011;32:347–50.
   PubMed Web of Science ®Google Scholar
• Scott GS, Spitsin SV, Kean RB, Mikheeva T, Koprowski H, Hooper DC. Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursors. Proc Natl Acad Sci USA 2002;99:16303–8.
   PubMed Web of Science ®Google Scholar
• Koch M, De Keyser J. Uric acid in multiple sclerosis. Neurol Res 2006;28:316–9.
   PubMed Web of Science ®Google Scholar
• Miller E, Mrowicka M, Malinowska K, Mrowicki J, Kędziora J. Effects of whole body cryotherapy on oxidative stress in multiple sclerosis patients. J Therm Biol 2010;35:406–10.
   Web of Science ®Google Scholar
• Liu L, Yenari M. Therapeutic hypothermia: neuroprotective mechanisms. Front Biosci 2007;12:816–25.
   PubMed Web of Science ®Google Scholar
• Lubkowska A, Dolegowska B, Szygula Z, Klimek A. Activity of selected enzymes in the erythrocytes and level of plasma antioxidants in response to single whole-body cryostimulation in humans. Scand J Clin Lab Invest 2009;69:387–94.
   PubMed Web of Science ®Google Scholar
• Gordon Ch J. Response of the thermoregulatory system to toxic insults. Front Biosci 2010;2:293–311.
   Google Scholar
• Miller E, Mrowicka M, Malinowska K, Żołyński K, Kędziora J. Effects of whole body cryotherapy on total antioxidative status and activities of antioxidative enzymes in blood of patients with multiple sclerosis. J Med Invest 2010;57:168–73.
   PubMedGoogle Scholar
• Miller E, Mrowicka M, Malinowska K, Mrowicki J, Saluk-Juszczak J, Kędziora J. Effects of whole body cryotherapy on a total antioxidative status and activity of antioxidant enzymes in blood of depressive multiple sclerosis patients. World J Biol Psychiatry 2011;12:223–7.
   PubMed Web of Science ®Google Scholar
• Rymaszewska J, Ramsey D, Chaładzińska-Kiejna S. Whole-body cryotherapy as adjunct treatment of depressive and anxiety disorders. Arch Immunol Ther Exp 2008;56:63–8.
   PubMed Web of Science ®Google Scholar
• Hirvonen HE, Mikkelsson MK, Kautiainen H, Pohjolainen TH, Leirisalo-Repo M. Effectiveness of different cryotherapies on pain and disease activity in active rheumatoid arthritis. A randomized single blinded controlled trial. Clin Exp Rheummatol 2006;24:295–301.
   PubMed Web of Science ®Google Scholar
• Harlaar J, Ten Kate JJ, Prevo AJ, Vogelaar TW, Lakhorst GJ. The effect of cooling on muscle coordination in spasticity: assessment with the repetitive movement test. Disabil Rehabilitat 2001;23:453–61.
   PubMed Web of Science ®Google Scholar
• Grahn DA, Murray JV, Heller HC. Cooling via one hand improves physical performance in heat-sensitive individuals with multiple sclerosis: preliminary study. BMC Neurol 2008;12:14.
   Google Scholar
• Meyer-Heim A, Rothmaier M, Weder M, Kool J, Schenk P, Kesselring J. Advanced lightweight cooling-garment technology: functional improvements in thermosensitive patients with multiple sclerosis. Mult Scler 2007;13:232–7.
   PubMed Web of Science ®Google Scholar
• Schwid SR, Petrie MD, Murray R, Leitch J, Bowmen J, Alquist A, Pelligrino R, Roberts A, Goldwater D, Cutter G, Webbon B; NASA/MS Cooling Study Group. A randomized controlled study of the acute and chronic effects of cooling therapy for MS. Neurology 2003;60:1955–60.
   PubMed Web of Science ®Google Scholar
• Beenakker EA, Oparina TI, Hartgring A, Teelken A, Arutjunyan AV, De Keyser J. Cooling garment treatment in MS: clinical improvement and decrease in leucocyte NO production. Neurology 2001;57:892–4.
   PubMed Web of Science ®Google Scholar
• Lubin FD, Reingold SC. Defining the clinical course of multiple sclerosis results of an international survey. National Multiple Sclerosis Society USA Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996;46:907–11.
   PubMed Web of Science ®Google Scholar
• Gregorowicz H, Zagrobelny Z. Systemic cryotherapy. Indications and contraindications, its course, and physiological and clinical results. Indygo Zahir Media 2007;4–16.
   Google Scholar
• Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444–52.
   PubMed Web of Science ®Google Scholar
• Bowman GL, Shannon J, Frei B, Kaye JA, Quinn JF. Uric acid as a CNS antioxidant. J Alzheimers Dis 2010;19: 1331–6.
   PubMed Web of Science ®Google Scholar
• Markowitz CE, Spitsin S, Zimmerman V, Jacobs D, Udupa JK, Hooper DC, Koprowski H. The treatment of multiple sclerosis with inosine. J Altern Complement Med 2009;15: 616–25.
   Google Scholar
• Ertürk C, Altay MA, Selek S, Kocyiğit A. Paraoxonase-1 activity and oxidative status in patients with knee osteoarthrosis and their relationship with radiological and clinical parameters. Scand J Clin Lab Invest 2012;72;433–9.
   PubMed Web of Science ®Google Scholar
• Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health. Physiol Rev 2007;87:315–424.
   PubMed Web of Science ®Google Scholar
• Galboiz Y, Miller A. Immunological indicators of disease activity and prognosis in multiple sclerosis. Curr Opin Neurol 2002;15:233–7.
   PubMed Web of Science ®Google Scholar